Walleye Trading’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,446
Closed -$226K 5345
2022
Q2
$226K Buy
+12,446
New +$258K ﹤0.01% 3599
2020
Q4
Sell
-737
Closed -$11.9K 4829
2020
Q3
$10K Sell
737
-3,436
-82% -$43.5K ﹤0.01% 3914
2020
Q2
$47K Sell
4,173
-53,169
-93% -$755K ﹤0.01% 3809
2020
Q1
$821K Buy
+57,342
New +$1.21M 0.01% 1451
2019
Q3
Sell
-314
Closed -$9.15K 4299
2019
Q2
$9K Sell
314
-5,054
-94% -$143K ﹤0.01% 3842
2019
Q1
$178K Sell
5,368
-23,719
-82% -$722K ﹤0.01% 3123
2018
Q4
$846K Buy
29,087
+21,604
+289% +$777K 0.01% 1901
2018
Q3
$344K Sell
7,483
-8,036
-52% -$357K ﹤0.01% 3283
2018
Q2
$580K Buy
+15,519
New +$524K ﹤0.01% 2693
2017
Q1
Sell
-23,365
Closed -$414K 4995
2016
Q4
$389K Buy
+23,365
New +$423K ﹤0.01% 2289
2016
Q3
Sell
-19,342
Closed -$491K 5220
2016
Q2
$592K Buy
19,342
+16,717
+637% +$581K ﹤0.01% 2066
2016
Q1
$98K Buy
2,625
+2,241
+584% +$84.4K ﹤0.01% 3353
2015
Q4
$17K Sell
384
-35,901
-99% -$1.52M ﹤0.01% 4511
2015
Q3
$1.36M Buy
36,285
+36,195
+40,217% +$1.28M 0.01% 874
2015
Q2
$3K Buy
+90
New +$3.06K ﹤0.01% 4618
2015
Q1
Sell
-1,418
Closed -$48K 4337
2014
Q4
$48K Buy
+1,418
New +$50.3K ﹤0.01% 3272
2013
Q3
Sell
-28,076
Closed -$754K 3123
2013
Q2
$754K Buy
+28,076
New +$814K 0.01% 1043

Other funds holding MYGN

Walleye Trading's MYGN Position: Q3 2022 in Review

Walleye Trading sold out of Myriad Genetics (MYGN) in Q3 2022, closing a stake of 12,446 shares — an estimated $226K sold.

Walleye Trading first reported a position in MYGN in Q2 2013 and held it in 17 quarters. The position peaked at $1.36M in Q3 2015. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.

  • Walleye Trading reported no remaining Myriad Genetics position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 12,446 Myriad Genetics shares in Q3 2022, an estimated $226K.
  • Walleye Trading first reported a position in Myriad Genetics in Q2 2013 and held it in 17 quarters.
  • Walleye Trading's Myriad Genetics position peaked at $1.36M in Q3 2015.
  • 191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.